A phase 2 study of three low-dose intensity subcutaneous bortezomib regimens in elderly frail patients with untreated multiple myeloma

A. Larocca, S. Bringhen, M. T. Petrucci, S. Oliva, A. P. Falcone, T. Caravita, O. Villani, G. Benevolo, A. M. Liberati, F. Morabito, V. Montefusco, R. Passera, L. de Rosa, P. Omedé, I. D. Vincelli, S. Spada, A. M. Carella, E. Ponticelli, D. Derudas, M. GenuardiT. Guglielmelli, C. Nozzoli, E. Aghemo, L. de Paoli, C. Conticello, C. Musolino, M. Offidani, M. Boccadoro, P. Sonneveld, A. Palumbo

Research output: Contribution to journalArticlepeer-review

Fingerprint Dive into the research topics of 'A phase 2 study of three low-dose intensity subcutaneous bortezomib regimens in elderly frail patients with untreated multiple myeloma'. Together they form a unique fingerprint.

Medicine & Life Sciences